Basic Information
RNALocate ID: | RLID:11001636 |
RNA Symbol: | hsa-let-7g-5p |
Localization: | Microvesicle |
RNA Information
RNA Name: | hsa-let-7g |
RNA ID: | miRBase:MIMAT0000414 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 23539611 |
Tissue/Cell Line: | Seminal plasma |
Method: | Microarray |
Description: | In order to assess the reversibility of post-vasectomy miRNA sequelae, we investigated whether SMV miRNAs altered by vasectomy could be retrieved in SMVs from normospermic vasovasostomized donors. miRNA microarray profiling performed on SMVs from normal, vasectomized and vasovasostomized donors identified 313 miRNAs whose intensity was above the threshold of detection. Among these miRNAs, 293 were detected in samples from normal donors, 275 in vasectomized donors and 298 in vasovasostomized donors (Fig. 3, Supplementary data, Table SIV). Data are collected from Table S4. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01001694 | Cytoplasm | Nasopharyngeal carcinoma cells | 20498841 |
RLID:01001695 | Cytoplasm | HeLa cells | 22058130 |
RLID:01001696 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001697 | Mitochondrion | HEK-293 cells|HeLa cells|Myotube | 27396686 |
RLID:01001698 | Mitochondrion | HEK-293 cells|HeLa cells|Skeletal muscle cells | 27563705 |
RLID:01001699 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
RLID:01001700 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
RLID:01001701 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001702 | Nucleolus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001703 | Nucleus | Nasopharyngeal carcinoma cells | 20498841 |
RLID:01001704 | Nucleus | HeLa cells | 22058130 |
RLID:11001622 | Exosome | Human cervical cancer cell line (HeLa) | 25760330 |
RLID:11001623 | Exosome | Hetastatic gastric cancer cell line (AZ-P7a) | 20949044 |
RLID:11001624 | Exosome | Breast cancer cell line (MCF-7) | 20976003 |
RLID:11001625 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
RLID:11001626 | Exosome | Renal cancer cells | 21670082 |
RLID:11001627 | Exosome | Breast milk | 22211110 |
RLID:11001628 | Exosome | Epidermal melanocytes (HEMa-LP)|Malignant melanoma cell line (A375) | 23056502 |
RLID:11001629 | Exosome | Saliva | 23302638 |
RLID:11001630 | Exosome | Brain tissue | 23382797 |
RLID:11001631 | Exosome | Plasma | 23663360 |
RLID:11001632 | Exosome | Human esophageal cancer cell line (EC9706) | 25184951 |
RLID:11001633 | Extracellular vesicle | HEK-293T cells | 22849433 |
RLID:11001634 | Microvesicle | Plasma | 19002258 |
RLID:11001635 | Microvesicle | Plasma | 23077538 |
RLID:11001637 | Microvesicle | Follicular fluid | 23666971 |
RLID:11001638 | Microvesicle | Hepatoma cells | 23771658 |
RLID-D:11000068 | Exosome | Blood|B lymphoblastoid cells|Breast milk|Chronic lymphocytic leukemia cells|Colon tissue|Endothelial cells|Epithelial cells|Mast cells|Seminal fluid|Tongue tissue | |
RLID-D:11000342 | Microvesicle | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-let-7g-5p | Diffuse large b cell lymphoma | MNDR-E-MI-01982 |
MNDR | hsa-let-7g-5p | Splenic marginal zone lymphoma | MNDR-E-MI-01983 |
MNDR | hsa-let-7g-5p | Oral squamous cell carcinoma | MNDR-E-MI-01984 |
MNDR | hsa-let-7g-5p | B cell lymphoma of malt type | MNDR-E-MI-01985 |
MNDR | hsa-let-7g-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-01986 |
MNDR | hsa-let-7g-5p | Lymphoma | MNDR-E-MI-01987 |
MNDR | hsa-let-7g-5p | Lymphoma non-hodgkin | MNDR-E-MI-01988 |
MNDR | hsa-let-7g-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-01989 |
MNDR | hsa-let-7g-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-01990 |
MNDR | hsa-let-7g-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-01991 |
MNDR | hsa-let-7g-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-01992 |
MNDR | hsa-let-7g-5p | Breast cancer luminal | MNDR-E-MI-01993 |
MNDR | hsa-let-7g-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-01994 |
MNDR | hsa-let-7g-5p | B cell acute lymphoblastic leukemia | MNDR-E-MI-01995 |
MNDR | hsa-let-7g-5p | Prostate cancer | MNDR-E-MI-01996 |
MNDR | hsa-let-7g-5p | Gastric cancer | MNDR-E-MI-01997 |
MNDR | hsa-let-7g-5p | Gastric lymphoma | MNDR-E-MI-01998 |
MNDR | hsa-let-7g-5p | Alzheimer disease | MNDR-E-MI-01999 |
MNDR | hsa-let-7g-5p | Dysautonomia familial | MNDR-E-MI-02000 |
MNDR | hsa-let-7g-5p | Head and neck cancer | MNDR-E-MI-02001 |
MNDR | hsa-let-7g-5p | Malaria | MNDR-E-MI-02002 |
MNDR | hsa-let-7g-5p | Leukemia | MNDR-E-MI-02003 |
MNDR | hsa-let-7g-5p | Cardiovascular disease | MNDR-E-MI-02004 |
MNDR | hsa-let-7g-5p | Lung cancer | MNDR-E-MI-02005 |
MNDR | hsa-let-7g-5p | Metabolic syndrome x | MNDR-E-MI-02006 |
MNDR | hsa-let-7g-5p | Parkinson disease | MNDR-E-MI-02007 |
MNDR | hsa-let-7g-5p | Breast cancer | MNDR-E-MI-02008 |
MNDR | hsa-let-7g-5p | Thyroid cancer | MNDR-E-MI-02009 |
MNDR | hsa-let-7g-5p | Pancreatic cancer | MNDR-E-MI-02010 |
MNDR | hsa-let-7g-5p | Melanoma | MNDR-E-MI-02011 |
MNDR | hsa-let-7g-5p | Rectum adenocarcinoma | MNDR-E-MI-02012 |
MNDR | hsa-let-7g-5p | Nephroblastoma | MNDR-E-MI-02013 |
MNDR | hsa-let-7g-5p | Colon cancer | MNDR-E-MI-02014 |
MNDR | hsa-let-7g-5p | Ischemic attack transient | MNDR-E-MI-02015 |
MNDR | hsa-let-7g-5p | Colon adenocarcinoma | MNDR-E-MI-02016 |
MNDR | hsa-let-7g-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-02017 |
MNDR | hsa-let-7g-5p | Familial ovarian cancer | MNDR-E-MI-02018 |
MNDR | hsa-let-7g-5p | Prostate adenocarcinoma | MNDR-E-MI-02019 |
MNDR | hsa-let-7g-5p | Carcinoma ductal breast | MNDR-E-MI-02020 |
MNDR | hsa-let-7g-5p | Glioblastoma | MNDR-E-MI-02021 |
MNDR | hsa-let-7g-5p | Malignant glioma | MNDR-E-MI-02022 |
MNDR | hsa-let-7g-5p | Chordoma | MNDR-E-MI-02023 |
MNDR | hsa-let-7g-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-02024 |
MNDR | hsa-let-7g-5p | Liposarcoma | MNDR-E-MI-02025 |
MNDR | hsa-let-7g-5p | Liver cancer | MNDR-E-MI-02026 |
MNDR | hsa-let-7g-5p | Uterine cancer | MNDR-E-MI-02027 |
MNDR | hsa-let-7g-5p | Cervical adenocarcinoma | MNDR-E-MI-02028 |
MNDR | hsa-let-7g-5p | Gastric adenocarcinoma | MNDR-E-MI-02029 |
MNDR | hsa-let-7g-5p | Non-small cell lung cancer | MNDR-E-MI-02030 |
MNDR | hsa-let-7g-5p | Lung adenocarcinoma | MNDR-E-MI-02031 |
MNDR | hsa-let-7g-5p | Adrenocortical cancer | MNDR-E-MI-02032 |
MNDR | hsa-let-7g-5p | Thyroid carcinoma | MNDR-E-MI-02033 |
MNDR | hsa-let-7g-5p | Tuberculosis | MNDR-E-MI-02034 |
MNDR | hsa-let-7g-5p | Carcinoma renal cell | MNDR-E-MI-02035 |
MNDR | hsa-let-7g-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-02036 |
MNDR | hsa-let-7g-5p | Clear cell renal cell carcinoma | MNDR-E-MI-02037 |
MNDR | hsa-let-7g-5p | Biliary tract cancer | MNDR-E-MI-02038 |
MNDR | hsa-let-7g-5p | Cholangiocarcinoma | MNDR-E-MI-02039 |
MNDR | hsa-let-7g-5p | Esophageal cancer | MNDR-E-MI-02040 |
MNDR | hsa-let-7g-5p | Liver cirrhosis | MNDR-E-MI-02041 |
MNDR | hsa-let-7g-5p | Testicular germ cell cancer | MNDR-E-MI-02042 |
MNDR | hsa-let-7g-5p | T acute lymphoblastic leukemia | MNDR-E-MI-02043 |
MNDR | hsa-let-7g-5p | Acute t cell leukemia | MNDR-E-MI-02044 |
MNDR | hsa-let-7g-5p | Breast invasive carcinoma | MNDR-E-MI-02045 |
MNDR | hsa-let-7g-5p | Early hepatocellular carcinoma | MNDR-E-MI-02046 |
MNDR | hsa-let-7g-5p | Familiar ovarian carcinoma | MNDR-E-MI-02047 |
MNDR | hsa-let-7g-5p | B-cell lymphoma | MNDR-E-MI-02048 |
MNDR | hsa-let-7g-5p | Rheumatoid arthritis | MNDR-E-MI-02049 |
MNDR | hsa-let-7g-5p | T-cell leukemia | MNDR-E-MI-02050 |
MNDR | hsa-let-7g-5p | Neuroblastoma | MNDR-E-MI-02051 |
MNDR | hsa-let-7g-5p | Hodgkin lymphoma | MNDR-E-MI-02052 |
MNDR | hsa-let-7g-5p | Burkitt lymphoma | MNDR-E-MI-02053 |
MNDR | hsa-let-7g-5p | Neurological disease | MNDR-E-MI-02054 |
MNDR | hsa-let-7g-5p | Crohn disease | MNDR-E-MI-02055 |
MNDR | hsa-let-7g-5p | Neuromyelitis optica | MNDR-E-MI-02056 |
MNDR | hsa-let-7g-5p | Acute myelogenous leukemia | MNDR-E-MI-02057 |
MNDR | hsa-let-7g-5p | Colorectal cancer | MNDR-E-MI-02058 |
MNDR | hsa-let-7g-5p | Nasopharynx carcinoma | MNDR-E-MI-02059 |
MNDR | hsa-let-7g-5p | Multiple myeloma | MNDR-E-MI-02060 |
MNDR | hsa-let-7g-5p | Nasopharyngeal cancer | MNDR-E-MI-02061 |
MNDR | hsa-let-7g-5p | Prostatic neoplasms | MNDR-E-MI-02062 |
MNDR | hsa-let-7g-5p | High grade dysplastic nodule | MNDR-E-MI-02063 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | ABCC10 | Homo sapiens | RR00023406 |
TOP